INS and Alzheimer disease: AD is also associated with increased oxidative stress [21,22,23], chronic inflammation [24,25,26,27], and cognitive deficits [28,29], as well as metabolic disturbances, such as impaired neuronal insulin signaling, impaired cerebral energy metabolism [30] and reduced glucose metabolism [31].